Drug Abuse
2
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
TevaIsrael - Petach Tikva
1 program1
45-mg hydrocodone bitartrate extended-release tabletPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Kyowa Hakko KirinIstradefylline
Teva45-mg hydrocodone bitartrate extended-release tablet
Clinical Trials (2)
Total enrollment: 142 patients across 2 trials
A Study to Evaluate Abuse Potential of Istradefylline
Start: Jan 2016Est. completion: Jul 201642 patients
Phase 1Completed
A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users
Start: Mar 2012Est. completion: May 2012100 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space